Início › Câncer de Pulmão › Illinois › Evanston
Ensaios clínicos de Câncer de Pulmão em Evanston, IL
19 estudos para Câncer de Pulmão estão buscando participantes em locais em Evanston e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecrutandoFase 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · a 5 mi de distância
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi de distância
- e mais 1
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi de distância
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RecrutandoFase 3
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi de distância
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RecrutandoFase 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi de distância
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecrutandoFase 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi de distância
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
RecrutandoFase 3
- North Shore University Health System ( Site 4014), Evanston
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecrutandoFase 3
- Illinois Cancer Specialists, Niles · a 6 mi de distância
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RecrutandoFase 3
- Illinois Cancer Specialists, Niles · a 6 mi de distância
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RecrutandoFase 3
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi de distância
A Registry for People With Lung Cancer
RecrutandoEstudo observacional
- Endeavor Health, Evanston
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
RecrutandoFase 3
- Illinois Cancer Specialists, Niles · a 6 mi de distância
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RecrutandoFase 3
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi de distância
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
RecrutandoFase 2
- Advocate Aurora Health, Park Ridge · a 8 mi de distância
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecrutandoFase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi de distância
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi de distância
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi de distância
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi de distância
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi de distância
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
RecrutandoVoluntários saudáveis bem-vindos
- Northwestern University, Evanston
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RecrutandoEstudo observacional
- Northshore University Health System, Evanston
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
RecrutandoEstudo observacional
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi de distância
Ensaios de Câncer de Pulmão em outras cidades
- Houston, TX78 estudos
- Boston, MA62 estudos
- New York City, NY60 estudos
- Los Angeles, CA45 estudos
- Washington, DC41 estudos
- Arlington, VA41 estudos
- Chicago, IL41 estudos
- Nashville, TN40 estudos
- Baltimore, MD40 estudos
- St. Louis, MO39 estudos
- Columbus, OH37 estudos
- Philadelphia, PA36 estudos
Outros estudos em Evanston
- Câncer de Pulmão de Não Pequenas Células22 estudos
- Câncer de Mama13 estudos
- Leucemia Mieloide Aguda11 estudos
- Obesidade11 estudos
- Câncer Colorretal10 estudos
- Câncer (todos os tipos)9 estudos
- Sobrepeso9 estudos
- Colite ulcerativa9 estudos
- Câncer de Próstata9 estudos
- Doença de Crohn9 estudos
- Insuficiência Cardíaca8 estudos
- Fibrilação Atrial8 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.